140 related articles for article (PubMed ID: 21247403)
1. Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy.
Mohanraj L; Oh Y
Recent Pat Anticancer Drug Discov; 2011 May; 6(2):166-77. PubMed ID: 21247403
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
5. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
6. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.
Christopoulos PF; Corthay A; Koutsilieris M
Cancer Treat Rev; 2018 Feb; 63():79-95. PubMed ID: 29253837
[TBL] [Abstract][Full Text] [Related]
7. IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer.
Cai Q; Dozmorov M; Oh Y
Cells; 2020 May; 9(5):. PubMed ID: 32443727
[TBL] [Abstract][Full Text] [Related]
8. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
Bermont L; Fauconnet S; Lamielle F; Adessi GL
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
[TBL] [Abstract][Full Text] [Related]
10. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells.
Nahta R; Yuan LX; Zhang B; Kobayashi R; Esteva FJ
Cancer Res; 2005 Dec; 65(23):11118-28. PubMed ID: 16322262
[TBL] [Abstract][Full Text] [Related]
12. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
Rozen F; Pollak M
Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
[TBL] [Abstract][Full Text] [Related]
14. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
Yee D; Jackson JG; Kozelsky TW; Figueroa JA
Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
18. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract][Full Text] [Related]
19. Influence of treatment with onapristone on the IGF-system in breast cancer patients.
Helle SI; Jonat W; Giurescu M; Ekse D; Holly JM; Lønning PE
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):159-63. PubMed ID: 9719450
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
